Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ja-Lok Ku

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 17, 2021
Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug ResponsesSoon-Chan Kim, Ji Won Park, Ha-Young Seo, et al.
International Journal of Oncology|October 22, 2013
Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell linesJa-Lok Ku, Sung-Chan Park, Kyung-Hee Kim, et al.
Journal of Human Genetics|September 16, 2004
A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndromeIl-Jin Kim, Hio Chung Kang, Yong Shin, et al.
Gut and Liver|December 17, 2021
Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration BiopsiesJee Hyung Lee, Haeryoung Kim, Sang Hyub Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2020
Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatmentYoung Eun Lee, Anna Ju, Hwi Wan Choi, et al.
Carcinogenesis|February 24, 2010
Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markersJa-Lok Ku, Young-Kyoung Shin, Duck-Woo Kim, et al.
Cellular and Molecular Life Sciences : CMLS|March 12, 2022
Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastomaSojin Kim, Soo-Ji Park, Tamrin Chowdhury, et al.
The American Journal of Pathology|June 24, 2003
Identification of novel cellular targets in biliary tract cancers using global gene expression technologyDonna E Hansel, Ayman Rahman, Manuel Hidalgo, et al.
Oncotarget|November 3, 2016
Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancerHae Ryung Chang, Seungyoon Nam, Jinhyuk Lee, et al.
Frontiers in Oncology|June 1, 2022
Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian CancerWenyu Wang, Untack Cho, Anna Yoo, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 17, 2021
Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug ResponsesSoon-Chan Kim, Ji Won Park, Ha-Young Seo, et al.
International Journal of Oncology|October 22, 2013
Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell linesJa-Lok Ku, Sung-Chan Park, Kyung-Hee Kim, et al.
Journal of Human Genetics|September 16, 2004
A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndromeIl-Jin Kim, Hio Chung Kang, Yong Shin, et al.
Gut and Liver|December 17, 2021
Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration BiopsiesJee Hyung Lee, Haeryoung Kim, Sang Hyub Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2020
Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatmentYoung Eun Lee, Anna Ju, Hwi Wan Choi, et al.
Carcinogenesis|February 24, 2010
Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markersJa-Lok Ku, Young-Kyoung Shin, Duck-Woo Kim, et al.
Cellular and Molecular Life Sciences : CMLS|March 12, 2022
Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastomaSojin Kim, Soo-Ji Park, Tamrin Chowdhury, et al.
The American Journal of Pathology|June 24, 2003
Identification of novel cellular targets in biliary tract cancers using global gene expression technologyDonna E Hansel, Ayman Rahman, Manuel Hidalgo, et al.
Oncotarget|November 3, 2016
Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancerHae Ryung Chang, Seungyoon Nam, Jinhyuk Lee, et al.
Frontiers in Oncology|June 1, 2022
Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian CancerWenyu Wang, Untack Cho, Anna Yoo, et al.
Pageof 12